Multiply Labs Teams Up with Legend Biotech for Innovations in Cell Therapy
Multiply Labs is making significant strides with its new partnership with Legend Biotech Corporation (NASDAQ: LEGN), a notable player in the field of cell therapy. This collaboration will focus on automating the manufacturing processes associated with cell therapy, which is a rapidly advancing industry.
Transforming Automated Manufacturing Processes
This partnership seeks to change the landscape of how cell therapies are produced. Multiply Labs is known for its advanced robotic systems that aim to make existing manufacturing processes smoother and more efficient. Unlike traditional approaches that often require extensive modifications, this novel method can implement automation with minimal disruption.
What's the Reason for the Collaboration?
Legend Biotech plans to evaluate Multiply Labs' robotic technologies, gaining early access to next-generation automated systems. By combining their strengths, both companies aspire to speed up the integration of robotics within the cell therapy sector. This effort is geared toward hastening the adoption of new technologies and improving the overall efficiency and effectiveness of drug production.
Impact on Cell Therapy Manufacturing
What makes this collaboration particularly intriguing is its potential to revolutionize cell therapy manufacturing. Multiply Labs' automation solutions are crafted to seamlessly operate with a wide array of instruments used in gene and cell therapy. This adaptability is essential given the varied needs of different organizations within this innovative industry.
An Insightful Study
A recent study by Multiply Labs showcased the success of their automated systems, detailed in a peer-reviewed journal. The findings revealed that robotic cell expansion processes can perform on par with traditional manual methods while significantly cutting down production costs. This evidence emphasizes the technology's promise in streamlining labor expenses and boosting output.
Leadership Perspectives
Fred Parietti, Ph.D., Co-founder and CEO of Multiply Labs, expressed his excitement regarding the partnership. He said, "This collaboration allows us to leverage our technology alongside top scientists in our industry. It highlights the power and potential of our flexible approach to automation and brings us closer to our goal of reducing labor costs and, eventually, increasing manufacturing throughput. We are eager to provide more accessible treatment options for patients." This vision captures the essence of what both companies aim to accomplish as they embark on this pioneering journey.
About Multiply Labs
Multiply Labs is leading the charge in robotics technology applied within the pharmaceutical sector. The company designs innovative, cloud-controlled robotic systems that enable large-scale production of customized drugs. Their clientele includes well-known organizations involved in advanced pharmaceutical manufacturing, which underscores their expertise at the intersection of robotics and the biopharma industry.
The founding team’s dedication to robotics began at MIT, where their shared interests sparked the creation of a company that marries engineering skill with biopharmaceutical innovation. Headquartered in San Francisco, California, Multiply Labs continues to expand the possibilities within drug manufacturing.
Frequently Asked Questions
What is the focus of the collaboration between Multiply Labs and Legend Biotech?
The collaboration aims to automate manufacturing processes in the cell therapy industry by leveraging innovative robotics technology.
How does Multiply Labs' automation technology affect production costs?
Multiply Labs’ automation minimizes production costs by matching the efficiency of manual processes while optimizing labor expenses.
What recent study supports the effectiveness of Multiply Labs' technology?
A peer-reviewed study published in Cytotherapy shows that robotic cell expansion processes can achieve statistical equivalence with traditional methods.
What is Multiply Labs' expertise in the industry?
Multiply Labs combines expertise in robotics and biopharma, featuring a team of engineers and scientists from various fields.
Where is Multiply Labs located?
The company is headquartered in San Francisco, California, and continues to innovate in automated drug manufacturing.
